Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss ONB Q1 2026 Earnings Narrow EPS Miss Slightly Below Estimates Stock Edges Higher ELPC Q2 2025 Earnings Strong EPS Beat Amid Mixed Market Sentiment China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment EFSCP Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower Charlton Aria Acquisition Corporation Rights CHARR Holds Steady at 011 SPAC Rights Remain RangeBound ACV Auctions ACVA Holds Steady Near Support as Market Awaits Direction Pinnacle Financial Partners PNFP Holds Steady Near 98 as Market Awaits Catalysts Oncolytics Biotech ONCY Gains 247 as Shares Approach Key Resistance at 085 Moodys MCO Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Amid Cautious Outlook